Andrew N. Schiff, Director at Aclaris Therapeutics, Inc. (ACRS), sold 14,648 shares at $16.16 ($237K) on 2022-10-07, disclosed to the SEC on 2022-10-11.
Open-market sale of $237k ACRS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.16 | 7,324 | $118K | 50.0% |
| 2 | $16.16 | 7,324 | $118K | 50.0% |
| Total | $16.16 avg | 14,648 | $237K | 100% |
| Filing → |
| ACRS | SELL | 2022-10-19 | $1.7M | — | Filing → |
| ACRS | SELL | 2022-10-06 | $1.5M | — | Filing → |
| ACRS | SELL | 2022-06-21 | $592K | — | Filing → |